ADVICENNE
Advicenne reports First Half financial results as of June 30, 2026, and updates on its activities
Advicenne reports First Half financial results as of June 30, 2026, and updates on its activities
Filed with Euronext ·
6ix is reading this filing.
View original source (Euronext)Advicenne SA on 6ix
Story so far
Earlier from Advicenne
- Advicenne Extends Its Cash Runway to 2028 Through Bond Financing and Strong Operational Performance
- Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
- Advicenne decides to withdraw its ADV7103 New Drug Application in the USA
- Advicenne Announces the Reimbursement of Sibnayal® for the Treatment of dRTA in Spain
- Advicenne: Net Revenue for the First Half of 2026 Driven by Reimbursement of Sibnayal® and Likozam® in France
Follow Advicenne into a list and get an email when it puts out news.
Follow Advicenne